• Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensi...

• Kim Tae-Suk

• Kim Ji-Hoon, Kim Baek-Hui, Lee Young-Sun, Yoo Yang-Jae, Kang Seong-Hee, Suh Sang-June, Jun...

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 340 ~ 346

• Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlle...

• Lee Kwan-Sik

• Kweon Young-Oh, Um Soon-Ho, Kim Byung-Ho, Lim Young-Suk, Paik Seung-Woon, Heo Jeong, Lee H...

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 331 ~ 339

• Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to ...

• Kim Hong-Joo

• Cho Yong-Kyun, Jeon Woo-Kyu, Kim Byung-Ik

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 323 ~ 330

• Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 pat...

• Shin Hyun-Phil

• Park Ji-Ae, Burman Blaire, Kozarek Richard A., Siddique Asma

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 316 ~ 322

• Lamivudine: fading into the mists of time

• Choi Jong-Gi

• Lim Young-Suk

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 314 ~ 315

• Is it possible to predict the development of an entecavir resistance mutation in patients with chron...

• Nam Joon-Yeul

• Lee Jeong-Hoon

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 311 ~ 313

• Use of sofosbuvir in chronic kidney disease: Is it necessary?

• Lim Tae-Seop

• Ahn Sang-Hoon

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 308 ~ 310

• Histopathological evaluation of liver fibrosis and cirrhosis regression

• Lo Regina C.

• Kim Hae-Ryoung

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 302 ~ 307

• Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification

• Lee Dong-Ho

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 290 ~ 301

• Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 ? a revie...

• Kim Tae-Kyoung

• Noh Seung-Yeon, Kono Yuko

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 280 ~ 289

• Treatment options after sorafenib failure in patients with hepatocellular carcinoma

• Dika Imane El

• Abou-Alfa Ghassan K.

• Clinical and Molecular Hepatology   2017  Volume.23  No.4 273 ~ 279